NewcelX NCEL
NASDAQ NCEL
$3.26 -0.11 (-3.18%)
As of: Aug 21, 2026 · 1:20 PM EDT

NewcelX (NCEL) Cash & Current Investments (2019 - 2025)

NewcelX (NCEL) posted quarterly Cash & Current Investments of $2.2 million for Q4 2025, up 238.62% year-over-year from $650000.0 in Q4 2024, and up 636.12% quarter-over-quarter from $299000.0 in Q2 2025.

NewcelX (NCEL) Cash & Current Investments (2019 - 2025) Analysis & Trends

NewcelX (NCEL) has reported Cash & Current Investments for 7 consecutive years, with $2.2 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Cash & Current Investments rose 238.62% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (up 238.62% YoY), while the FY2025 annual figure was $2.2 million, up 238.62% from the prior year.
  • Cash & Current Investments improved to $2.2 million in Q4 2025 per NCEL's latest filing, from $299000.0 in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $7.1 million in Q2 2021 and bottomed at $299000.0 in Q2 2025.
  • Historically, Cash & Current Investments has averaged $2.2 million across 5 years, with a median of $1.3 million in 2022.
  • Annual changes were most pronounced in 2021 — Cash & Current Investments soared 5695.69% — and 2022, when it plunged 80.91%.
  • NewcelX's Cash & Current Investments stood at $5.4 million in 2021, then tumbled by 66.56% to $1.8 million in 2022, then slumped by 36.89% to $1.1 million in 2023, then tumbled by 43.28% to $650000.0 in 2024, then surged by 238.62% to $2.2 million in 2025.
  • Business Quant data shows NCEL's Cash & Current Investments at $2.2 million in Q4 2025, $299000.0 in Q2 2025, and $650000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 NewcelX 12.54 Mn 10.34 Mn - 2.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.20 Mn
Jun 30, 2025 299,000.00
Dec 31, 2024 650,000.00
Jun 30, 2024 548,000.00
Dec 31, 2023 1.15 Mn
Jun 30, 2023 1.13 Mn
Dec 31, 2022 1.82 Mn
Jun 30, 2022 1.35 Mn
Dec 31, 2021 5.43 Mn
Jun 30, 2021 7.09 Mn
Dec 31, 2020 93,711.00
Dec 31, 2019 220,267.00